Linus Health unveils enhancements to its dementia early detection platform
At HIMSS24, the company, known for its digital approach to brain health evaluation, also has revealed it has acquired Aural Analytics, a vendor of clinical-grade speech analytics.
Linus Health, a digital health company enabling early detection of Alzheimer’s and other dementias, today at HIMSS24 has introduced two upgrades to its platform and the acquisition of a related vendor.
It has debuted a new Digital Trail Making Test Part B, an FDA Class II- listed medical device designed to capture far more data than a paper-based exam, and has introduced a Hearing Screener system to its AI-enhanced digital cognitive assessment platform.
The company also has revealed it has acquired Aural Analytics, a vendor of clinical-grade speech analytics. The deal includes Aural Analytics' assets, including its technology and intellectual property.
Healthcare IT News interviewed Dr. John Showalter, chief product officer at Linus Health, to get the lowdown on all the news.
CLICK HERE TO READ THE COMPLETE STORY
Healthcare Compliance & Program Management Leader Specializing in: Legal Operations, Regulatory Compliance, Training and Development, Policy & Procedures
3 周Fantastic read. What an exciting time to be in healthcare, a far overdue brag.
Well done!
Award-Winning Healthcare Executive
11 个月Very excited about what we will be able to do for patients.
Chief Strategy Officer at Amendola Communications, part of Supreme Group
11 个月Great article, Bill! Really exciting stuff for anyone who has had a loved one touched by dementia.